Pregled bibliografske jedinice broj: 327463
Long-lasting partial regression of glioblastoma multiforme achieved by edotecarin: case report.
Long-lasting partial regression of glioblastoma multiforme achieved by edotecarin: case report. // Croatian Medical Journal, 47 (2006), 2; 305-309 (recenziran, članak, stručni)
CROSBI ID: 327463 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Long-lasting partial regression of glioblastoma multiforme achieved by edotecarin: case report.
Autori
Vrdoljak, Eduard ; Boban, M. ; Saratlija-Novaković, Z. ; Jović, J.
Izvornik
Croatian Medical Journal (0353-9504) 47
(2006), 2;
305-309
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, stručni
Ključne riječi
topoisomerase I inhibitor; edotecarin; recurring glioblastoma
Sažetak
We describe the response to a new chemotherapy agent, topoisomerase I inhibitor edotecarin in an 18-year-old woman with recurring glioblastoma. The therapy was administered for 17 months. The radiological partial response and clinical improvement have been achieved, with minor toxicity. Median survival of patients with glioblastoma is 10 months. With edotecarin we have achieved promising result, which should encourage further investigations to develop more efficient therapy for such a deadly disease.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Split
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
